Suppression of Tumor Growth Following Intralesional Therapy with TRAIL Recombinant Adenovirus
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (3) , 257-266
- https://doi.org/10.1006/mthe.2001.0439
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytesCurrent Opinion in Immunology, 1999
- Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivoNature Medicine, 1999
- TRAIL: a molecule with multiple receptors and control mechanismsCurrent Opinion in Immunology, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Apoptosis signaling by death receptorsEuropean Journal of Biochemistry, 1998
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Mechanisms and Genes of Cellular SuicideScience, 1995
- The Fas Death FactorScience, 1995